Outcomes of contemporary novel agent incorporation in relapsed/refractory PTCL

Tolu, S. S., Seshadri, M. R., Chen, Z., Orlando, E., Grenet, J., Toor, R., Sanjurjo, A., Phillips, A., Shore, T., Martin, P., Leonard, J. P., Pro, B., Amengual, J. E., & Ruan, J. (2023). Outcomes of contemporary novel agent incorporation in relapsed/refractory PTCL. Hematological Oncology, 41(S2), 511–512. Portico. https://doi.org/10.1002/hon.3164_377
Authors:
Seda S. Tolu
M R Seshadri
Z. Chen
Evelyn Orlando
J. Grenet
Rubinder Toor
A. Sanjurjo
Anna Evans Phillips
Tsiporah B. Shore
Peter Martin
John P. Leonard
Barbara Pro
Jennifer E. Amengual
Jia Ruan
Affiliated Authors:
Seda S. Tolu
Evelyn Orlando
A. Sanjurjo
Barbara Pro
Jennifer E. Amengual
Columbia Affiliation:
Subjects:
Human T-cell Leukemia Virus Type 1 Infection (OpenAlex Topic)
Lymphoid Neoplasms (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1002/hon.3164_377
DOI:
10.1002/hon.3164_377
Journal:
Hematological Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: